California Courts of Appeal
Jun. 19, 2013
Generic drugmaker can be sued for failing to update warning label, appellate court rules
A pharmaceutical company can be sued for failing to update a warning label on a generic drug to match the label on the corresponding brand-name drug, a state appellate court has ruled.
Daily Journal Staff Writer
A pharmaceutical company can be sued for failing to update a warning label on a generic drug to match the label on the corresponding brand-name drug, a state appellate court has ruled.
The decision opens the door for plaintiffs to seek damages from Teva Pharmaceuticals USA Inc. for failing to update the label on the generic form of Fosamax, which helps prevent osteoporosis, to indicate it can cause fe...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In